the european commission (s) announced on wednesday the approval of the sixth eu covid-19 vaccine strategy contract, this time with the pharmaceutical company moderna.
"i am very pleased to announce today's agreement with moderna to purchase up to 160 million doses of its future vaccine. this is our sixth contract with a vaccine manufacturer and we are working on another one," said european commission president ursula von der lien.
she noted that ec is building "one of the most comprehensive portfolios of covid-19 vaccines in the world." "a safe and effective vaccine can help us end the pandemic and gradually return to normal life," said the head of the ec.
in the communiqué of the european commission, it is reported that the next contract provides for the initial purchase of 80 million doses on behalf of all eu member states, as well as the opportunity to request further 80 million doses, which will be delivered after the vaccine proves its safety and effectiveness against covid-19.
brussels reminds that moderna complements the portfolio of vaccines to be produced in europe. it already includes contracts signed with astrazeneca, sanofi-gsk, janssen pharmaceutica nv, biontech-pfizer, and a contract with curevac approved by the ec.
"this diversified portfolio of vaccines will ensure europe is well prepared for vaccination once it is proven safe and effective," communique notes
with full or partial use of site materials, a link to "version.com" is required.
all information about the information provided by the agency "interfax-ukraine", do not want to see a new version of the agency, whether it is